Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Lipids Health Dis ; 9: 142, 2010 Dec 16.
Article in English | MEDLINE | ID: mdl-21162733

ABSTRACT

BACKGROUND: Statins induces cell cycle arrest, apoptosis, reduction of angiogenic factors, inhibition of the endothelial growth factor, impairing tissue adhesion and attenuation of the resistance mechanisms. The aim of this study was evaluate the anti-tumoral activity of simvastatin in a B16F10 melanoma-mouse model. METHODS: Melanoma cells were treated with different concentrations of simvastatin and assessed by viability methods. Melanoma cells (5 × 10(4)) were implanted in two month old C57Bl6/J mice. Around 7 days after cells injection, the oral treatments were started with simvastatin (5 mg/kg/day, p.o.). Tumor size, hematological and biochemical analyses were evaluated. RESULTS: Simvastatin at a concentration of 0.8 µM, 1.2 µM and 1.6 µM had toxic effect. Concentration of 1.6 µM induced a massive death in the first 24 h of incubation. Simvastatin at 0.8 µM induces early cell cycle arrest in G0/G1, followed by increase of hypodiploidy. Tumor size were evaluated and the difference of treated group and control, after ten days, demonstrates that simvastatin inhibited the tumor expansion in 68%. CONCLUSION: Simvastatin at 1.6 µM, presented cytototoxicity after 72 h of treatment, with an intense death. In vivo, simvastatin being potentially useful as an antiproliferative drug, with an impairment of growth after ten days.


Subject(s)
Antineoplastic Agents/therapeutic use , Melanoma/drug therapy , Simvastatin/therapeutic use , Animals , Cell Cycle/drug effects , Cell Line, Tumor , Flow Cytometry , Liver/drug effects , Male , Melanoma/pathology , Mice , Mice, Inbred C57BL , Spleen/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...